The Banff 2017 Kidney Meeting Report : Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
Haas, Mark (Cedars-Sinai Medical Center)
Loupy, Alexandre (Université Paris Cité)
Lefaucheur, Carmen (Université Paris VII and INSERM U 1160. Hopital Saint Louis)
Roufosse, C. (Imperial College London and North West London Pathology)
Glotz, Denis (Université Paris VII and INSERM U 1160. Hopital Saint Louis)
Serón Micas, Daniel (Hospital Universitari Vall d'Hebron)
Nankivell, B. J. (Westmead Hospital)
Halloran, P. F. (University of Alberta)
Colvin, Robert (Harvard Medical School)
Akalin, Enver (Montefiore Medical Center)
Alachkar, Nada (Johns Hopkins University School of Medicine)
Bagnasco, Serena (Johns Hopkins University School of Medicine)
Bouatou, Y. (Geneva University Hospitals (Ginebra, Suïssa))
Becker, Jan U. (Uniklinik Köln (Colònia, Alemanya))
Cornell, Lynn (Mayo Clinic (Rochester, Estats Units d'Amèrica))
van Huyen, J. P. Duong (Université Paris Cité)
Gibson, Ian W. (University of Manitoba)
Kraus, Edward S. (Johns Hopkins University)
Mannon, R. B. (University of Alabama School of Medicine)
Naesens, Maarten (UZ Leuven)
Nickeleit, V. (The University of North Carolina School of Medicine)
Nickerson, P. (University of Manitoba)
Segev, D. L. (Johns Hopkins Medical Institutions)
Singh, H. K. (The University of North Carolina School of Medicine)
Stegall, M. (Mayo Clinic (Rochester, Estats Units d'Amèrica))
Randhawa, P. (University of Pittsburgh)
Racusen, Lorraine (Johns Hopkins University School of Medicine)
Solez, Kim (University of Alberta)
Mengel, Michael (University of Alberta)
Universitat Autònoma de Barcelona

Data:	2018
Resum:	The kidney sessions of the 2017 Banff Conference focused on 2 areas: clinical implications of inflammation in areas of interstitial fibrosis and tubular atrophy (i-) and its relationship to T cell-mediated rejection (), and the continued evolution of molecular diagnostics, particularly in the diagnosis of antibody-mediated rejection (). In confirmation of previous studies, it was independently demonstrated by 2 groups that i- is associated with reduced graft survival. Furthermore, these groups presented that i-, particularly when involving.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Classification systems: Banff classification ; Kidney transplantation/nephrology ; Molecular biology ; Pathology/histopathology ; Rejection ; Translational research/science
Publicat a:	American Journal of Transplantation, Vol. 18, Issue 2 (February 2018) , p. 293-307, ISSN 1600-6143

DOI: 10.1111/ajt.14625
PMID: 29243394

15 p, 1.1 MB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats